A group of T-ALL cell lines with the mutated CREBBP allele were resistant to glucocorticoid dexamethasone treatment but sensitive to clinically useful concentrations of class I/II HDACi vorinostat [68]. Here, CREBBP is linked to acute lymphoblastic leukemia.